SC 13D/A | 2019-05-14 | TPG Group Holdings (SBS) Advisors, Inc. | Alliqua BioMedical, Inc. | 1,112,290 | 18.9% | EDGAR |
SC 13D | 2019-05-13 | Domain Partners VIII, L.P. | Alliqua BioMedical, Inc. | 3,036,044 | 52.3% | EDGAR |
SC 13G/A | 2019-02-14 | PERCEPTIVE ADVISORS LLC | Alliqua BioMedical, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2018-02-14 | PERCEPTIVE ADVISORS LLC | Alliqua BioMedical, Inc. | 429,108 | 8.6% | EDGAR |
SC 13G/A | 2018-02-12 | Tekla Capital Management LLC | Alliqua BioMedical, Inc. | 165,000 | 3.3% | EDGAR |
SC 13D/A | 2017-06-27 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 9,025,194 | 18.8% | EDGAR |
SC 13D/A | 2017-04-13 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 8,321,471 | 19.9% | EDGAR |
SC 13D/A | 2017-03-29 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 8,025,194 | 19.9% | EDGAR |
SC 13D/A | 2017-03-16 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 8,025,194 | 19.9% | EDGAR |
SC 13D/A | 2017-03-01 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 8,025,194 | 22.2% | EDGAR |
SC 13G/A | 2017-02-14 | PERCEPTIVE ADVISORS LLC | Alliqua BioMedical, Inc. | 1,921,951 | 6.7% | EDGAR |
SC 13G/A | 2017-02-14 | Flynn James E | Alliqua BioMedical, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-13 | Tekla Capital Management LLC | Alliqua BioMedical, Inc. | 1,650,000 | 5.6% | EDGAR |
SC 13G/A | 2017-01-10 | SABBY MANAGEMENT, LLC | Alliqua BioMedical, Inc. | 1,100,398 | 3.7% | EDGAR |
SC 13G | 2016-03-31 | SABBY MANAGEMENT, LLC | Alliqua BioMedical, Inc. | 1,488,108 | 5.4% | EDGAR |
SC 13G/A | 2016-02-16 | PERCEPTIVE ADVISORS LLC | Alliqua BioMedical, Inc. | 1,921,951 | 7.0% | EDGAR |
SC 13G/A | 2016-02-16 | Flynn James E | Alliqua BioMedical, Inc. | 1,880,134 | 6.8% | EDGAR |
SC 13G | 2016-02-12 | Tekla Capital Management LLC | Alliqua BioMedical, Inc. | 1,650,000 | 6.0% | EDGAR |
SC 13G/A | 2015-05-08 | PERCEPTIVE ADVISORS LLC | Alliqua BioMedical, Inc. | 1,921,951 | 7.9% | EDGAR |
SC 13D/A | 2015-05-04 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 4,025,194 | 15.9% | EDGAR |